MiMedx

Is your practice expanding? Are you treating an increasing number of patients? The WoundGenex Premier Graft Purchasing Program provides a solution by allowing you to acquire MIMEDX human placental allografts with no upfront costs. This credit extension supports rapidly growing practices, enabling them to offer advanced wound therapies to more patients in need. Discover more about the Premier Graft Purchasing Program and other valuable WoundGenex services: https://bit.ly/3xFGJxk #MIMEDX #WoundGenex #WoundCare

A NEW publication on a Medicare Big Data Review of VLUs showed improved patient outcomes while reducing healthcare resource utilization. Find out more: https://bit.ly/3PAXWy0 #MIMEDX #WOUNDS #Medicare #WoundCare

We're excited to sponsor the inaugural International Post-Acute Woundcare Society Summit on September 5th and 6th in New Orleans! Stop by our booth to explore MIMEDX's portfolio of human placental allografts. We look forward to connecting with you! #MIMEDX #WoundCare #IPAWS2024

It’s great to see our team’s enthusiasm after another successful strategy meeting in Weehawken, NJ! It’s always inspiring to see our sales force come together to learn, share best practices, and connect with one another. #MIMEDX #TeamWork #InnovationInHealthcare

Navigating reimbursement documentation can be challenging. WoundGenex's Clinical Documentation Improvement (CDI) program is designed to provide guidance and help minimize the risk of clawbacks, adding additional security to your reimbursements! Interested in learning more? https://bit.ly/3V4g2Mf #MIMEDX #WoundGenex #Reimbursement #WoundCare

We had an incredible time at the Wild On Wounds conference in Phoenix, AZ! A huge thank you to all the healthcare providers who joined us for our live human placental dissection, visited us at our booth, and attended our educational dinner. Your enthusiasm and dedication to advancing clinical science is truly inspiring. Check out some highlights from the event in the photos below. 📸 Curious to learn more about the science behind our solutions? Click here: https://bit.ly/41mNpLw #MIMEDX #WOW2024 #WildOnWounds #WoundCare #HealthcareInnovation

HELIOGEN™ is your new go-to for managing moderately to heavily exudating acute surgical and chronic wounds and for controlling minor bleeding. Whether it's pressure ulcers, venous stasis ulcers, diabetic ulcers, or partial-thickness burns, HELIOGEN has you covered. Want to be among the first to experience this game-changer? Click here to discover more: https://bit.ly/HELIOGEN #MIMEDX #HELIOGEN #SurgicalInnovations #SurgicalSolutions

Will you be at the Congress of Neurological Surgeons Annual Meeting? Are you interested in learning about the use of advanced human placental allografts in spine and neurosurgery? Register today for MIMEDX’s exclusive educational dinner event to learn about the evidence and clinical uses of placental allografts. Spots are limited! Reserve yours today: http://bit.ly/CNS_Dinner #MIMEDX #CNS2024 #Surgery #Neurosurgery #SkinSubstitutes

MIMEDX is excited to introduce HELIOGEN™, the latest addition to our advanced surgical solutions portfolio! HELIOGEN is intended for the management of moderately to heavily exudating acute surgical and chronic wounds and to control minor bleeding in wounds such as pressure ulcers, venous stasis ulcers, diabetic ulcers, and partial-thickness burns. Would you like to be one of the first to try it? Click here to learn more: https://bit.ly/HELIOGEN #MIMEDX #HELIOGEN #SurgicalInnovations #SurgicalSolutions

After 15 weeks of SOC with limited progress, Dr. Oltmann chose to use EPIEFFECT to help her patient with a chronic Wagner Grade III diabetic foot ulcer. With only 5 applications, Dr. Oltmann observed closure using EPIEFFECT as a protective barrier as part of the treatment protocol to support the healing cascade and aid in the development of granulation tissue. Learn more about EPIEFFECT: https://bit.ly/3UFcIYb   Thank you, Megan Oltmann, DPM, FACFAS, for sharing your experience with EPIEFFECT! #MIMEDX #EPIEFFECT #WoundCare